American Tungsten Corp. (TSXV: TUNG, OTCQB: DEMRF)
Building America’s Defense Critical Metals Supply
As the global nuclear renaissance accelerates, Canadian uranium giant Cameco (TSX: CCO) has become a market focus. The stock has surged 625% over the past five years and is up 88% year-to-date, but its price-to-earnings (P/E) ratio of 84 has raised valuation concerns. The core question for investors is: Is it still worth considering at current highs?
Earnings Surge: Nuclear Demand Drives Growth
In the first half of 2025, Cameco’s revenue increased 35% year-over-year to $1.7 billion, with net profit reaching $321 million. Key growth drivers include: rising uranium prices, which pushed the average long-term contract price to $87 per pound, up from $84 at the beginning of the year; a 49% stake in Westinghouse, which contributed $126 million in earnings in a single quarter due to a nuclear reactor project in the Czech Republic, leading to an upward revision of full-year EBITDA expectations to $525–580 million.
Meanwhile, the restart of the McArthur River and Cigar Lake mines, which improved economies of scale and could stabilize operating margins above 15%.
Strategic Advantages: Integrated Layout and Long-Term Contracts
Cameco’s core competitiveness lies in three areas: securing annual deliveries of 28 million pounds of uranium through long-term contracts until 2029; an integrated business model spanning uranium mining, conversion, nuclear fuel services, and next-generation nuclear technology (e.g., the Global Laser Enrichment project); strong financials, with $716 million in cash reserves, only $1 billion in debt, and an unused $1 billion credit facility.
These factors position Cameco as a key alternative supplier for Europe and the U.S. seeking to reduce dependence on Russian nuclear fuel, highlighting its geopolitical value.
Valuation Debate: Can High Growth Justify the Premium?
Despite strong fundamentals, risks cannot be ignored as well:
Valuation Pressure: A P/E ratio of 84 is significantly higher than the 10 P/E of Kazakh uranium giant Kazatomprom. If revenue growth slows to single digits, the valuation multiple may compress;
Policy Risks: Potential tariffs on uranium products under a Trump administration could impact short-term profits;
Operational Risks: Equipment commissioning at new mining sites and global trade tensions could affect production capacity.
Analysts project annual earnings per share (EPS) growth of 10.8% over the next five years. If EPS reaches $2 by 2030 and the P/E multiple contracts to 40, the stock price could fall to $80 (currently $106).
Investment Advice: Long-Term Positioning Over Short-Term Chase
Regarding whether to consider buying Cameco stock at current levels:
For long-term investors, nuclear demand growth is highly certain (with 31 countries globally increasing nuclear investments), and Cameco, as an industry leader, is well-positioned to benefit. Buying on pullbacks to the $90–95 range could be a strategy;
For short-term traders, the current valuation already reflects optimistic expectations, warranting caution about technical corrections.
It is worth noting that Cameco’s dividend yield is only 0.15%, making it unsuitable for income-oriented investors. Its value realization depends on earnings growth and sustained valuation multiples.
Conclusion: Embrace the Nuclear Wave, but Avoid Overpaying
Cameco is a high-quality player in the nuclear renaissance, but its current valuation requires flawless execution of growth plans. Investors may consider waiting for technical pullbacks or diversifying timing risks through periodic investments. After all, in the long cycle of energy transition, opportunities are never scarce—but a margin of safety remains the first principle of investing.
